SEC Form 4 · accession 0001179110-19-003116
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert E Funck
Officer — Senior Vice President
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Feb 28, 2019 | F | 4,680 | $77.23 | D | 139,993 | D | |
| Common shares without par value | Mar 1, 2019 | S | 1,002 | $78.00 | D | 138,991 | D | |
| Common shares without par valueF1 | holding | — | — | — | 17,297 | I | Profit Sharing Trust | |
| Common shares without par valueF2 | holding | — | — | — | 500 | I | By Daughter | |
| Common shares without par valueF2 | holding | — | — | — | 500 | I | By Daughter |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2019.
- F2The reporting person disclaims beneficial ownership of all securities held by his daughter.